Primary aldosteronism (PA) and endothelial progenitor cell (EPC) bioavailability.
about
Impairment of endothelial progenitor cell function and vascularization capacity by aldosterone in mice and humans.Endothelial progenitor cells and their potential clinical implication in cardiovascular disorders.Aldosterone affects blood flow and vascular tone regulated by endothelium-derived NO: therapeutic implications.
P2860
Primary aldosteronism (PA) and endothelial progenitor cell (EPC) bioavailability.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Primary aldosteronism (PA) and endothelial progenitor cell (EPC) bioavailability.
@en
type
label
Primary aldosteronism (PA) and endothelial progenitor cell (EPC) bioavailability.
@en
prefLabel
Primary aldosteronism (PA) and endothelial progenitor cell (EPC) bioavailability.
@en
P2093
P1476
Primary aldosteronism (PA) and endothelial progenitor cell (EPC) bioavailability.
@en
P2093
Andrea Verhovez
Annarita Zeoli
Franco Veglio
Fulvio Morello
Maria Felice Brizzi
Paolo Mulatero
Tracy Ann Williams
P304
P356
10.1111/J.1365-2265.2008.03271.X
P577
2008-04-10T00:00:00Z